General behavior, toxicity, and cytotoxic activity of elenoside, a lignan from Justicia hyssopifolia

被引:68
作者
Navarro, E [1 ]
Alonso, SJ
Trujillo, J
Jorge, E
Pérez, C
机构
[1] Univ La Laguna, Fac Med, Dept Pharmacol, E-38071 La Laguna, Tenerife, Spain
[2] CSIC, Ctr Prod Nat & Agrobiol, E-38206 Tenerife, Spain
来源
JOURNAL OF NATURAL PRODUCTS | 2001年 / 64卷 / 01期
关键词
D O I
10.1021/np9904861
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Cytotoxicity, acute toxicity, and general pharmacological effects in mice of an arylnaphthalene lignan isolated from Justicia hyssopifolia were studied. Elenoside was cytotoxic to human cancer cell lines in a range of concentrations from 10(-5) to 10(-4) M. It has an LD50, ip in mice, of 305 mg/kg and central depressive properties at doses of 25, 50, and 100 mg/kg. Thus, elenoside appears to be a sedative with broad spectrum cytotoxicity.
引用
收藏
页码:134 / 135
页数:2
相关论文
共 14 条
[1]  
Boyd M. R., 1989, CANCER PRINCIPLES PR, V3, P1
[2]  
BRAMWELL D, 1990, FLORES SILVESTRES IS, P276
[3]  
DELANOIS AL, 1973, INT ENCY PHARM THERA, V2, P984
[4]   CYTO-TOXIC LIGNANS FROM PODOPHYLLUM, AND THE NOMENCLATURE OF ARYLTETRALIN LIGNANS [J].
DEWICK, PM ;
JACKSON, DE .
PHYTOCHEMISTRY, 1981, 20 (09) :2277-2280
[5]   CHEMICAL-CONSTITUENTS OF JUSTICA .2. NEW FUROFURANO LIGNANS FROM JUSTICIA-SIMPLEX [J].
GHOSAL, S ;
BANERJEE, S ;
JAISWAL, DK .
PHYTOCHEMISTRY, 1980, 19 (02) :332-334
[6]   JUSTICIDIN-B, A BIOACTIVE TRACE LIGNAN FROM THE SEEDS OF SESBANIA-DRUMMONDII [J].
HUI, YH ;
CHANG, CJ ;
MCLAUGHLIN, JL ;
POWELL, RG .
JOURNAL OF NATURAL PRODUCTS, 1986, 49 (06) :1175-1176
[7]   COMPREHENSIVE OBSERVATIONAL ASSESSMENT .IA. A SYSTEMATIC QUANTITATIVE PROCEDURE FOR ASSESSING BEHAVIORAL AND PHYSIOLOGIC STATE OF MOUSE [J].
IRWIN, S .
PSYCHOPHARMACOLOGIA, 1968, 13 (03) :222-&
[8]   (+)-NORTRACHELOGENIN, A NEW PHARMACOLOGICALLY ACTIVE LIGNAN FROM WIKSTROEMIA-INDICA [J].
KATO, A ;
HASHIMOTO, Y .
LLOYDIA-THE JOURNAL OF NATURAL PRODUCTS, 1979, 42 (02) :159-162
[9]  
LIM RKS, 1964, PHARM TECHNIQUES DRU, P294
[10]  
Moritani S, 1996, BIOL PHARM BULL, V19, P1515, DOI 10.1248/bpb.19.1515